Abstract
Knowledge of the acute cardiovascular effects of cannabis consumption remains largely
unknown and is important given the changing landscape of legalization of recreational
cannabis use. “4/20” is an annual event where many individuals gather to consume cannabis.
An increased risk of adverse health events such as motor vehicle accidents has previously
been reported to occur on “4/20.” In this study, population-based administrative databases
in Ontario, Canada, were used to evaluate the association between “4/20” and cardiovascular
events. An increased risk of cardiovascular events on a population level was not observed
on “4/20.” Additional research into the changes in the prevalence of the use of cannabis
with recreational legalization and acute and chronic risk with cannabis use is suggested.
Résumé
La connaissance des effets cardiovasculaires aigus de la consommation de cannabis
est largement méconnue, mais elle est importante dans le contexte évolutif de la légalisation
de l’usage du cannabis à des fins récréatives. Le 4/20 est un événement annuel où
de nombreux amateurs se rassemblent pour consommer du cannabis. Un risque accru d’incidents
ayant des conséquences négatives sur la santé, comme les accidents de la route, a
déjà été signalé dans le cadre du 4/20. Dans cette étude, les chercheurs ont utilisé
des bases de données administratives fondées sur la population de l’Ontario, au Canada,
pour évaluer l’association entre le 4/20 et les événements cardiovasculaires. Aucun
risque accru d’événements cardiovasculaires n’a été observé au sein de la population
dans le cadre du 4/20. Il est recommandé d’effectuer d’autres études sur l’évolution
de la prévalence de l’usage du cannabis dans le contexte de la légalisation à des
fins récréatives et sur les risques aigus et chroniques liés à l’usage du cannabis.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic and PersonalCorporate R&D ProfessionalsOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- World Drug Report 2018—Analysis of Drug Markets: Opiates, Cocaine, Cannabis, Synthetic Drugs.UNOCD, New York2018
- Associations between marijuana use and cardiovascular risk factors and outcomes: a systematic review.Ann Intern Med. 2018; 168: 187-194
- Triggering myocardial infarction by marijuana.Circulation. 2001; 103: 2805-2809
- Analysis of trends in the prevalence of cannabis use in Canada, 1985 to 2015.Health Rep. 2018; 29: 10-20
- Changes in marijuana use across the 2012 Washington state recreational legalization: Is retrospective assessment of use before legalization more accurate?.J Stud Alcohol Drugs. 2018; 79: 495-502
Article Info
Publication History
Published online: July 19, 2019
Accepted:
May 16,
2019
Received:
March 28,
2019
Footnotes
See page 1591 for disclosure information.
Identification
Copyright
© 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
